| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |